Implantable Optical Waveguide Conduits for Next‑Gen Neural Interfaces (Biocompatible and Implantable Optical Conduits, Tech ID: 15‑023)
Technology Overview: This NJIT technology delivers biocompatible, implantable optical conduits that route light to and from deep or peripheral tissues for sensing, stimulation, and diagnostics. Engineered as flexible waveguide structures, the conduits maintain optical transmission while minimizing tissue irritation and fibrotic response. They can couple to external light sources or detectors to enable optogenetic stimulation, neural photometry, or in‑situ spectroscopy, providing a durable optical interface where electrical leads are impractical or noisy.
Industry Pain Point: Traditional implant leads and fibers are bulky, rigid, and prone to inflammatory response or optical loss in vivo.
NJIT Solution: Soft, biocompatible optical conduits provide stable light delivery/collection with improved tissue conformity and longevity.
Key Features & Advantages
- Biocompatible, flexible waveguides for chronic implants
- Efficient optical coupling with low attenuation
- Compatible with optogenetics and implantable sensors
- Reduced tissue trauma vs. rigid optics
Development Stage: TRL 4–5 – Laboratory validation and preclinical prototyping.
Target Markets
- Neuroprosthetics & neuromodulation
- Optogenetics research tools
- Implantable diagnostics
Market Opportunity
- Neurostimulation devices (2026): ~$10B • CAGR: ~9–10% • 2035: ~$22–25B
Commercial & IP Details
Inventors: Mesut Sahin, Ali Ersen